EUVIMEDEUVIMED entdecken
Crossref

CXCR4 as a prognostic marker in Egyptian chronic lymphocytic leukemia patients

Wafaa El-sherif, Eman Salah El-din, Mai Aly, Mohamed Said, Dalia Nigm

Egyptian journal of Immunology · 2021

DOI: 10.55133/eji.280312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian journal of Immunology, 2021. Verfasst von Wafaa El-sherif und 4 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic lymphocytic leukemia (CLL) has variable clinical presentations, and molecular and biological prognostic markers. The C-X-C chemokine receptor 4 (CXCR4) and its ligand stromal cell-derived factor-1 (SDF-1) play an important role in trafficking of lymphocytes and monocytes. The aim was to study lymphocyte expression of CXCR4 and its prognostic value in CLL. A case control study was carried out on 30 newly diagnosed CLL cases and 30 healthy controls. Fludarabine, cyclophosphamide, and rituximab (FCR) was the standard treatment. Flowcytometric measurement of CXCR4 expression on lymphocytes was done. CXCR4 was significantly higher in patients than controls (81.67 ± 17.95 vs. 11.78 ± 2.78; P< 0.001). CXCR4 was significantly higher (P

Zitieren

APA

El-sherif, W., El-din, E. S., Aly, M., Said, M., & Nigm, D. (2021). CXCR4 as a prognostic marker in Egyptian chronic lymphocytic leukemia patients. Egyptian journal of Immunology. https://doi.org/10.55133/eji.280312

Vancouver

El-sherif W, El-din ES, Aly M, Said M, Nigm D. CXCR4 as a prognostic marker in Egyptian chronic lymphocytic leukemia patients. Egyptian journal of Immunology. 2021. doi:10.55133/eji.280312

BibTeX
@article{Elsherif2021,
  author = {El-sherif, Wafaa and El-din, Eman Salah and Aly, Mai and Said, Mohamed and Nigm, Dalia},
  title = {CXCR4 as a prognostic marker in Egyptian chronic lymphocytic leukemia patients},
  journal = {Egyptian journal of Immunology},
  year = {2021},
  doi = {10.55133/eji.280312}
}
Kostenlos starten →